Hubei Guangji Pharmaceutical Co (SZSE:000952) Other Net Income (Loss) : ¥-0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Hubei Guangji Pharmaceutical Co Other Net Income (Loss)?

Hubei Guangji Pharmaceutical Co's Other Net Income (Loss) for the three months ended in Sep. 2024 was ¥0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.0 Mil.

Hubei Guangji Pharmaceutical Co's quarterly Other Net Income (Loss) increased from Mar. 2024 (¥0.0 Mil) to Jun. 2024 (¥0.0 Mil) but then declined from Jun. 2024 (¥0.0 Mil) to Sep. 2024 (¥0.0 Mil).

Hubei Guangji Pharmaceutical Co's annual Other Net Income (Loss) increased from Dec. 2021 (¥-0.0 Mil) to Dec. 2022 (¥0.0 Mil) and increased from Dec. 2022 (¥0.0 Mil) to Dec. 2023 (¥0.0 Mil).

Hubei Guangji Pharmaceutical Co Other Net Income (Loss) Historical Data

The historical data trend for Hubei Guangji Pharmaceutical Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Guangji Pharmaceutical Co Other Net Income (Loss) Chart

Hubei Guangji Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Hubei Guangji Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Hubei Guangji Pharmaceutical Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.0 Mil.

Hubei Guangji Pharmaceutical Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Hubei Guangji Pharmaceutical Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Guangji Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Guangji Pharmaceutical Co Ltd (SZSE:000952) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Jiangdi Road, Hubei, Wuxue, CHN, 435400

Website

http://www.guangjipharm.com

Hubei Guangji Pharmaceutical Co Ltd is engaged in the manufacture and sale of raw pharmaceutical products, medicinal feed additives, fine chemicals and preparations in China. Geographically the business activities are carried out through China, however, more than 60 percent of its main products are exported to over 30 countries and regions all over the world.

Executives

Zou Guang Ming	Independent director
Guo Shao Zhi	Executives
Zhang Bin	Director
Guo Wen Chao	Supervisors
Sun Zhen Hua	Director
Liao Qing Jiang	Director
Wang Xin	Directors, executives
Hu Feng Lei	Supervisors
Ruan Zhong Yi	Executives
Zhang Ping	Director

Hubei Guangji Pharmaceutical Co Headlines

No Headlines